Hint mode is switched on Switch off

Stem Cells Spin, ordinary share
SCS, PLSTCLS00013

Add a stock to WL
Choose all Reset all
Stem Cells Spin, сountry — Poland
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Formed in 2009 and headquartered in Wrocław, Poland, Stem Cells Spin S.A., is a publicly traded biotechnology company focused on the development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care ...
Formed in 2009 and headquartered in Wrocław, Poland, Stem Cells Spin S.A., is a publicly traded biotechnology company focused on the development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. The company's proprietary solutions are based on an internationally patented technology stemming from a decade-long R&D program involving stem cells derived from growing red deer antlers by a team of scientists at Wrocław Medical University in Poland.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Stem Cells Spin S.A.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Indicators

Holders

Industry Leaders

Registration is required to get access.